Aldose reductase inhibitor increases doxorubicin-sensitivity of colon cancer cells and decreases cardiotoxicity
出版年份 2017 全文链接
标题
Aldose reductase inhibitor increases doxorubicin-sensitivity of colon cancer cells and decreases cardiotoxicity
作者
关键词
-
出版物
Scientific Reports
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-06-05
DOI
10.1038/s41598-017-03284-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mechanisms of drug resistance in colon cancer and its therapeutic strategies
- (2016) Tao Hu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Emerging delivery systems to reduce doxorubicin cardiotoxicity and improve therapeutic index
- (2015) Esther Tahover et al. ANTI-CANCER DRUGS
- Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN Loss
- (2015) Ting Zhong et al. BIOMEDICINE & PHARMACOTHERAPY
- Redundancy: A Critical Obstacle to Improving Cancer Therapy
- (2015) O. Lavi CANCER RESEARCH
- Cardiotoxicity of anticancer treatments
- (2015) Michael S. Ewer et al. Nature Reviews Cardiology
- Serum biomarkers evaluation to predict chemotherapy-induced cardiotoxicity in breast cancer patients
- (2015) Francesca De Iuliis et al. TUMOR BIOLOGY
- Aldose reductase inhibition suppresses azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice
- (2014) Ashish Saxena et al. CANCER LETTERS
- ROS Function in Redox Signaling and Oxidative Stress
- (2014) Michael Schieber et al. CURRENT BIOLOGY
- Deregulation of cell signaling in cancer
- (2014) Filippo G. Giancotti FEBS LETTERS
- Prevention of Anthracycline-Induced Cardiotoxicity
- (2014) Pimprapa Vejpongsa et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Gene signatures of drug resistance predict patient survival in colorectal cancer
- (2014) Y Zheng et al. PHARMACOGENOMICS JOURNAL
- Mechanism-Based Engineering Against Anthracycline Cardiotoxicity
- (2013) Thomas Force et al. CIRCULATION
- Aldose reductase inhibition suppresses colon cancer cell viability by modulating microRNA-21 mediated programmed cell death 4 (PDCD4) expression
- (2013) Ashish Saxena et al. EUROPEAN JOURNAL OF CANCER
- Aldose reductase inhibition enhances TRAIL-induced human colon cancer cell apoptosis through AKT/FOXO3a-dependent upregulation of death receptors
- (2013) Mohammad Shoeb et al. FREE RADICAL BIOLOGY AND MEDICINE
- The FLT3 Inhibitor Quizartinib Inhibits ABCG2 at Pharmacologically Relevant Concentrations, with Implications for Both Chemosensitization and Adverse Drug Interactions
- (2013) Jasjeet Bhullar et al. PLoS One
- Cytokines as Mediators of Chemotherapy-Associated Cognitive Changes: Current Evidence, Limitations and Directions for Future Research
- (2013) Yin Ting Cheung et al. PLoS One
- Aldose Reductase Inhibition Prevents Colon Cancer Growth by Restoring Phosphatase and Tensin Homolog Through Modulation of miR-21 and FOXO3a
- (2012) Ashish Saxena et al. ANTIOXIDANTS & REDOX SIGNALING
- Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization
- (2012) Allan D Heibein et al. BMC CANCER
- Molecular Pathways: Regulation and Therapeutic Implications of Multidrug Resistance
- (2012) K. G. Chen et al. CLINICAL CANCER RESEARCH
- Aldo–Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant Cancers
- (2012) Toshiyuki Matsunaga et al. Frontiers in Pharmacology
- Inhibition of aldose reductase prevents angiogenesis in vitro and in vivo
- (2011) Ravinder Tammali et al. ANGIOGENESIS
- Endothelial vascular toxicity from chemotherapeutic agents: Preclinical evidence and clinical implications
- (2011) Aspasia Soultati et al. CANCER TREATMENT REVIEWS
- Inhibition of aldose reductase prevents colon cancer metastasis
- (2011) Ravinder Tammali et al. CARCINOGENESIS
- Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders
- (2011) Satish K. Srivastava et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Aldose Reductase Inhibition Prevents Hypoxia-induced Increase in Hypoxia-inducible Factor-1α (HIF-1α) and Vascular Endothelial Growth Factor (VEGF) by Regulating 26 S Proteasome-mediated Protein Degradation in Human Colon Cancer Cells
- (2011) Ravinder Tammali et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group
- (2011) Linlin Zhong et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808
- (2010) J. E. Kolitz et al. BLOOD
- Crosstalk of reactive oxygen species and NF-κB signaling
- (2010) Michael J Morgan et al. CELL RESEARCH
- Reactive oxygen species in cancer
- (2010) Geou-Yarh Liou et al. FREE RADICAL RESEARCH
- Inhibition of Aldose Reductase Prevents Growth Factor–Induced G1-S Phase Transition through the AKT/Phosphoinositide 3-Kinase/E2F-1 Pathway in Human Colon Cancer Cells
- (2010) Kota V. Ramana et al. MOLECULAR CANCER THERAPEUTICS
- Reversal of ABC Drug Transporter-Mediated Multidrug Resistance in Cancer Cells: Evaluation of Current Strategies
- (2010) Chung-Pu Wu et al. Current Molecular Pharmacology
- Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk Factors
- (2009) Fatima Haggar et al. Clinics in Colon and Rectal Surgery
- Redox Regulation of Multidrug Resistance in Cancer Chemotherapy: Molecular Mechanisms and Therapeutic Opportunities
- (2008) Macus Tien Kuo ANTIOXIDANTS & REDOX SIGNALING
- Chemotherapeutic drugs and human tumor cells cytokine network
- (2008) Vera Levina et al. INTERNATIONAL JOURNAL OF CANCER
- Inactivation of the anticancer drugs doxorubicin and oracin by aldo–keto reductase (AKR) 1C3
- (2008) Romana Novotna et al. TOXICOLOGY LETTERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started